Danaher Corporation reported earnings results for the first quarter ended March 28, 2025. For the first quarter, the company reported sales was USD 5,741 million compared to USD 5,796 million a year ago. Net income was USD 954 million compared to USD 1,088 million a year ago. Basic earnings per share from continuing operations was USD 1.33 compared to USD 1.47 a year ago. Diluted earnings per share from continuing operations was USD 1.32 compared to USD 1.45 a year ago. Danaher Corporation reported earnings results for the first quarter ended March 28, 2025. For the first quarter, the company reported sales was USD 5,741 million compared to USD 5,796 million a year ago. Net income was USD 954 million compared to USD 1,088 million a year ago. Basic earnings per share from continuing operations was USD 1.33 compared to USD 1.47 a year ago. Diluted earnings per share from continuing operations was USD 1.32 compared to USD 1.45 a year ago.
Danaher is a Washington-based medical device company that manufactures and supplies testing instruments and diagnostic equipment for the healthcare industry across the globe.